A combination comprising combretastatin and anticancer agents

Details for Australian Patent Application No. 2002304574 (hide)

Owner Aventis Pharma S.A.

Inventors Bissery, Marie-Christine

Agent Watermark

Pub. Number AU-B-2002304574

PCT Number PCT/EP02/06758

PCT Pub. Number WO2004/037258

Priority 60/275,627 15.03.01 US

Filing date 15 March 2002

Wipo publication date 13 May 2004

Acceptance publication date 15 September 2005

International Classifications

A61K 031/4745

A61K 031/704

A61P 035/00 Antineoplastic agents

A61P 035/00 Antineoplastic agents

A61K 031/165 - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 031/47 - Quinolines

A61K 031/337 - having four-membered rings, e.g. taxol

A61K 031/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 031/4745

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/275,627 15.03.01 US

8 July 2004 Application Open to Public Inspection

  Published as AU-B-2002304574

15 September 2005 Application Accepted

  Published as AU-B-2002304574

2 February 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002304575-MAGNETIC SENSOR BASED ON BALLISTIC MAGNETORESISTANCE USING A PINHOLE MULTILAYER SYSTEM

2002304573-METHOD FOR PRODUCING COMPOSITE ELEMENTS